❌

Normal view

Received — 15 September 2026 ⏭ Journals

Oncogene - Issue - nature.com science feeds
Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis Tao Xie · Tianming Peng · Qu Li · Mingzhao Li · Maoping Cai · Qianyi Li · Yu-Zhong Yu · Jiehui Zhong · Chong Wang · Ming-Kun Chen · Zhe-Sheng Chen · Xian-Lu Song · Di Gu · Shan-Chao Zhao
Oncogene, Published online: 11 September 2026; doi:10.1038/s41388-026-03976-6Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis
11 September 2026 at 08:00

Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis

Oncogene - Issue - nature.com science feeds

By: Tao Xie · Tianming Peng · Qu Li · Mingzhao Li · Maoping Cai · Qianyi Li · Yu-Zhong Yu · Jiehui Zhong · Chong Wang · Ming-Kun Chen · Zhe-Sheng Chen · Xian-Lu Song · Di Gu · Shan-Chao Zhao

11 September 2026 at 08:00

Oncogene, Published online: 11 September 2026; doi:10.1038/s41388-026-03976-6

Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis

Received — 13 April 2026 ⏭ Journals

npj Digital Medicine
Evaluating AI in leukocyte classification: performance of the AI system against 15 morphology experts Wei Xu · Haoqin Jiang · Jingxian Zhang · Kun Chen · Yang Fei · Ping Guo · Yongjian He · Yi Ye · Linlin Qu · Mingkang Yang · Lizhi Yan · Di Wang · Huan Qi · Shihong Zhang · Chi Zhang · Jianbiao Wang · Ming Guan
npj Digital Medicine, Published online: 11 April 2026; doi:10.1038/s41746-026-02601-wEvaluating AI in leukocyte classification: performance of the AI system against 15 morphology experts
11 April 2026 at 08:00

Evaluating AI in leukocyte classification: performance of the AI system against 15 morphology experts

npj Digital Medicine

By: Wei Xu · Haoqin Jiang · Jingxian Zhang · Kun Chen · Yang Fei · Ping Guo · Yongjian He · Yi Ye · Linlin Qu · Mingkang Yang · Lizhi Yan · Di Wang · Huan Qi · Shihong Zhang · Chi Zhang · Jianbiao Wang · Ming Guan

11 April 2026 at 08:00

npj Digital Medicine, Published online: 11 April 2026; doi:10.1038/s41746-026-02601-w

Evaluating AI in leukocyte classification: performance of the AI system against 15 morphology experts

Received — 14 March 2026 ⏭ Journals

Nature - Issue - nature.com science feeds
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma Jiawei Lv · Dan-Xue Zheng · Jin-Hui Liang · Ning Zhang · Zu-Lu Ye · Xu-Dong Xu · Melvin. L. K. Chua · Lu-Lu Zhang · Zi-Ming Du · Zi-Chen Zhang · Wen-Fei Li · Ling-Long Tang · Lei Chen · Yan-Ping Mao · Rui Guo · Yu-Pei Chen · Li Lin · Yuan Zhang · Xu Liu · Cheng Xu · Zhi-Xuan Li · Ling-Xin Xu · Pan-Yang Yang · Kun Chen · Deng Bin · Tian-Sheng Gao · Jian-Ye Yan · Lu-Si Chen · Shao Hui Huang · Hong-Yun Zhao · Shu-Bin Hong · Yu-Sheng Jie · Hui-Ling Huang · Xu-Hua Tang · Jing-Ping Yun · Li-Zhi Liu · Li Tian · Hao-Jiang Li · Ji-Bin Li · Guan-Qun Zhou · Jun Ma · Ying Sun
Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10244-wA clinical trial testing whether monitoring ctDNA clearance during treatment for nasopharyngeal cancer could be used to inform decisions about an individual’s subsequent therapeutic programme shows promising results.
11 March 2026 at 08:00

Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma

Nature - Issue - nature.com science feeds

By: Jiawei Lv · Dan-Xue Zheng · Jin-Hui Liang · Ning Zhang · Zu-Lu Ye · Xu-Dong Xu · Melvin. L. K. Chua · Lu-Lu Zhang · Zi-Ming Du · Zi-Chen Zhang · Wen-Fei Li · Ling-Long Tang · Lei Chen · Yan-Ping Mao · Rui Guo · Yu-Pei Chen · Li Lin · Yuan Zhang · Xu Liu · Cheng Xu · Zhi-Xuan Li · Ling-Xin Xu · Pan-Yang Yang · Kun Chen · Deng Bin · Tian-Sheng Gao · Jian-Ye Yan · Lu-Si Chen · Shao Hui Huang · Hong-Yun Zhao · Shu-Bin Hong · Yu-Sheng Jie · Hui-Ling Huang · Xu-Hua Tang · Jing-Ping Yun · Li-Zhi Liu · Li Tian · Hao-Jiang Li · Ji-Bin Li · Guan-Qun Zhou · Jun Ma · Ying Sun

11 March 2026 at 08:00

Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10244-w

A clinical trial testing whether monitoring ctDNA clearance during treatment for nasopharyngeal cancer could be used to inform decisions about an individual’s subsequent therapeutic programme shows promising results.